LT2563906T - Cho ląstelių kultivavimo būdas - Google Patents

Cho ląstelių kultivavimo būdas

Info

Publication number
LT2563906T
LT2563906T LTEP11715933.5T LT11715933T LT2563906T LT 2563906 T LT2563906 T LT 2563906T LT 11715933 T LT11715933 T LT 11715933T LT 2563906 T LT2563906 T LT 2563906T
Authority
LT
Lithuania
Prior art keywords
cultivation
cho cells
cho
cells
Prior art date
Application number
LTEP11715933.5T
Other languages
English (en)
Inventor
Christoph E. Joosten
Christian Leist
Jörg Schmidt
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44041460&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2563906(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of LT2563906T publication Critical patent/LT2563906T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
LTEP11715933.5T 2010-04-26 2011-04-25 Cho ląstelių kultivavimo būdas LT2563906T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32784610P 2010-04-26 2010-04-26
PCT/EP2011/056507 WO2011134919A2 (en) 2010-04-26 2011-04-25 Improved cell cultivation process

Publications (1)

Publication Number Publication Date
LT2563906T true LT2563906T (lt) 2018-02-26

Family

ID=44041460

Family Applications (2)

Application Number Title Priority Date Filing Date
LTEP11715933.5T LT2563906T (lt) 2010-04-26 2011-04-25 Cho ląstelių kultivavimo būdas
LTEP17199357.9T LT3330370T (lt) 2010-04-26 2011-04-25 Cho ląstelių auginimo būdas

Family Applications After (1)

Application Number Title Priority Date Filing Date
LTEP17199357.9T LT3330370T (lt) 2010-04-26 2011-04-25 Cho ląstelių auginimo būdas

Country Status (18)

Country Link
US (1) US8765413B2 (lt)
EP (3) EP3862423A1 (lt)
JP (2) JP5980772B2 (lt)
KR (1) KR101828624B1 (lt)
CN (2) CN102858954A (lt)
AU (1) AU2011246502B2 (lt)
BR (1) BR112012027430B1 (lt)
CA (1) CA2795461C (lt)
DK (2) DK3330370T3 (lt)
ES (2) ES2659117T3 (lt)
IL (1) IL222454B (lt)
LT (2) LT2563906T (lt)
MX (1) MX2012012528A (lt)
PL (2) PL2563906T3 (lt)
PT (2) PT3330370T (lt)
RU (1) RU2577972C2 (lt)
SG (1) SG185014A1 (lt)
WO (1) WO2011134919A2 (lt)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201516149A (zh) 2006-09-13 2015-05-01 Abbvie Inc 細胞培養改良
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
CA2932207A1 (en) 2008-10-20 2010-12-09 Abbvie Inc. Isolation and purification of antibodies using protein a affinity chromatography
CN104974251A (zh) 2008-10-20 2015-10-14 Abbvie公司 在抗体纯化过程中的病毒灭活
CN102858953B (zh) 2010-04-26 2015-09-09 诺瓦提斯公司 改进的细胞培养基
LT2563906T (lt) 2010-04-26 2018-02-26 Novartis Ag Cho ląstelių kultivavimo būdas
BR112013009934A2 (pt) * 2010-12-07 2016-07-05 Hoffmann La Roche dispositivo para adicionar pelo menos duas soluções de alimentação, aparelho de cultivo celular, uso de um dispositivo e método para obter um polipeptídeo
US9133493B2 (en) 2011-04-21 2015-09-15 Amgen Inc. Method for culturing mammalian cells to improve recombinant protein production
WO2012149197A2 (en) 2011-04-27 2012-11-01 Abbott Laboratories Methods for controlling the galactosylation profile of recombinantly-expressed proteins
EP2809773B1 (en) 2012-01-30 2020-09-02 Dr. Reddy's Laboratories Limited Process of modulating man5 and/or afucosylation content of glycoprotein composition
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
HK1211981A1 (en) 2012-09-02 2016-06-03 Abbvie Inc. Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
EP2906683B1 (en) 2012-10-15 2017-05-31 Bristol-Myers Squibb Company Mammalian cell culture processes for protein production
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
AR095196A1 (es) 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
SG10201809452RA (en) 2013-03-15 2018-11-29 Genentech Inc Cell culture compositions with antioxidants and methods for polypeptide production
KR101439195B1 (ko) 2013-04-18 2014-09-12 동아대학교 산학협력단 에셰리키아 콜리 a-53 균주를 이용하여 섬유소 분해효소의 생산성을 향상시키는 공정
NZ715246A (en) * 2013-07-06 2017-07-28 Cadila Healthcare Ltd Improved process for production of monoclonal antibodies
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
RS59881B1 (sr) 2014-02-27 2020-03-31 Hoffmann La Roche Modulacija ćelijskog rasta i glikozilacije u rekombinantnoj proizvodnji glikoproteina
BR112016030659B1 (pt) 2014-08-11 2023-04-11 F. Hoffmann-La Roche Ag Uso de meta-tirosina, processo para a produção de um polipeptídeo e método para aumentar a produtividade específica de uma célula hospedeira eucariótica
KR20160049390A (ko) 2014-10-27 2016-05-09 삼성전자주식회사 산알 배양용 조성물 및 이를 이용한 산알 배양 방법
CA2986625A1 (en) 2015-05-22 2016-12-01 Csl Behring Recombinant Facility Ag Methods for preparing modified von willebrand factor
HU231463B1 (hu) * 2015-08-04 2024-01-28 Richter Gedeon Nyrt. Módszer rekombináns proteinek galaktóz tartalmának növelésére
WO2017065559A1 (ko) 2015-10-15 2017-04-20 (주)알테오젠 Igg fc 도메인을 가지는 융합 단백질의 생산방법
KR101936049B1 (ko) * 2015-10-15 2019-01-08 (주)알테오젠 IgG Fc 도메인을 가지는 융합 단백질의 생산방법
WO2018018613A1 (zh) 2016-07-29 2018-02-01 广东东阳光药业有限公司 一种提高抗体纯度的细胞培养基和培养方法
JP7213180B2 (ja) 2016-10-19 2023-01-26 エフ．ホフマン－ラ ロシュ アーゲー 免疫コンジュゲートを製造するための方法
GB201708655D0 (en) 2017-05-31 2017-07-12 Ucb Biopharma Sprl Cell culture methods
CN111406112A (zh) 2017-11-30 2020-07-10 豪夫迈·罗氏有限公司 用于培养哺乳动物细胞的工艺
EP3492582A1 (en) 2017-12-01 2019-06-05 UCB Biopharma SPRL Cell culture methods
CN109517738A (zh) * 2018-12-14 2019-03-26 杭州奕安济世生物药业有限公司 一种调控生物反应器中二氧化碳含量的方法
US12297451B1 (en) 2019-10-25 2025-05-13 Regeneron Pharmaceuticals, Inc. Cell culture medium
EP4196597A2 (en) * 2020-08-14 2023-06-21 Bristol-Myers Squibb Company Manufacturing process for protein
GB202012991D0 (en) 2020-08-20 2020-10-07 Ucb Biopharma Sprl Cell culture processes
JP7822149B2 (ja) * 2020-10-02 2026-03-02 ファイザー・インク Ｒｓｖ ｆタンパク質生産のための細胞培養工程
GB202105424D0 (en) 2021-04-16 2021-06-02 UCB Biopharma SRL Cell culture processes
CN120603928A (zh) * 2022-11-09 2025-09-05 伊孚森有限公司 避免冷凝的培养箱
GB202318647D0 (en) 2023-12-06 2024-01-17 Ucb Biopharma Sprl Cell culture processes

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672502A (en) * 1985-06-28 1997-09-30 Celltech Therapeutics Limited Animal cell culture
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
GB9118664D0 (en) 1991-08-30 1991-10-16 Celltech Ltd Cell culture
USH1532H (en) 1993-11-03 1996-05-07 Genetics Institute, Inc. Adaption of mammalian cell lines to high cell densities
US5856179A (en) 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
US6656466B1 (en) 1995-06-06 2003-12-02 Genetech, Inc. Human tumor necrosis factor—immunoglobulin(TNFR1-IgG1) chimera composition
JP4306813B2 (ja) 1995-09-19 2009-08-05 アスビオファーマ株式会社 動物細胞の新規培養方法
EP2221361A3 (en) 1996-08-30 2011-02-09 Life Technologies Corporation Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium
US20020012991A1 (en) 1997-04-07 2002-01-31 Florence Chua Nee Ho Kit Fong Cell culture media for enhanced protein production
TR200504220T2 (tr) 1998-12-17 2007-04-24 Biogen Idec Ma Inc. Aktif limfotoksin-beta reseptör imunoglobülin şimeAktif limfotoksin-beta reseptör imunoglobülin şimerik proteinlerinin yüksek düzey ifadesi ve saflaştrik proteinlerinin yüksek düzey ifadesi ve saflaştırılması için bir yöntem.ırılması için bir yöntem.
RU2215748C2 (ru) * 1999-04-09 2003-11-10 Сентро Де Инмунология Молекулар Способ получения рекомбинантного эритропоэтина человека и полученный эритропоэтин, фармацевтическая композиция
EP1757700A3 (en) * 1999-04-26 2009-03-11 Genentech, Inc. Cell culture process for glycoproteins
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
WO2002076578A1 (en) 2001-03-27 2002-10-03 Smithkline Beecham Corporation Control of glycoforms in igg
US20030087372A1 (en) 2001-06-13 2003-05-08 Genentech, Inc. Methods of culturing animal cells and polypeptide production in animal cells
CN1158388C (zh) * 2001-09-29 2004-07-21 陈志南 连续灌流式培养杂交瘤细胞制备抗体的方法
US20050069979A1 (en) * 2001-11-28 2005-03-31 Steffen Zeng Cell culture process
US20030190710A1 (en) 2002-03-28 2003-10-09 Devries Ruth L. Control of glycoforms in IgG
US6924124B1 (en) 2002-08-23 2005-08-02 Immunex Corporation Feeding strategies for cell culture
EP1575998A4 (en) 2002-12-23 2007-07-25 Bristol Myers Squibb Co PROCESS FOR CULTIVATING MAMMALIAN CELLS FOR PROTEIN PRODUCTION
TWI328614B (en) 2002-12-23 2010-08-11 Bristol Myers Squibb Co Product quality enhancement in mammalian cell culture processes for protein production
US7300773B2 (en) 2004-08-27 2007-11-27 Wyeth Research Ireland Limited Production of TNFR-Ig
US7335491B2 (en) 2004-08-27 2008-02-26 Wyeth Research Ireland Limited Production of anti-abeta
US7294484B2 (en) 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides
DK2041270T3 (da) 2006-07-13 2014-01-27 Wyeth Llc Fremstilling af glycoproteiner
WO2008013809A1 (en) 2006-07-24 2008-01-31 Amgen Inc. Cell culture methods
TW201516149A (zh) * 2006-09-13 2015-05-01 Abbvie Inc 細胞培養改良
MX2009004519A (es) 2006-11-03 2009-05-12 Wyeth Corp Sustancias que inhiben la glucolisis en un cultivo de celulas.
MX2009004974A (es) 2006-11-08 2009-05-20 Wyeth Corp Medios diseñado racionalmente para cultivo celular.
KR101540823B1 (ko) 2007-03-30 2015-07-30 메디뮨 엘엘씨 항체 제제
TW200902708A (en) 2007-04-23 2009-01-16 Wyeth Corp Methods of protein production using anti-senescence compounds
WO2008136398A1 (ja) * 2007-04-26 2008-11-13 Chugai Seiyaku Kabushiki Kaisha 高濃度アミノ酸含有培地を用いた細胞の培養方法
ES2392701T3 (es) 2007-05-11 2012-12-13 Amgen Inc. Medios de alimentación mejorados
LT2563906T (lt) 2010-04-26 2018-02-26 Novartis Ag Cho ląstelių kultivavimo būdas

Also Published As

Publication number Publication date
DK3330370T3 (da) 2021-05-10
US8765413B2 (en) 2014-07-01
PL3330370T3 (pl) 2021-09-20
CN107254499A (zh) 2017-10-17
IL222454B (en) 2018-11-29
EP2563906A2 (en) 2013-03-06
WO2011134919A2 (en) 2011-11-03
BR112012027430A2 (pt) 2015-09-22
JP2016214254A (ja) 2016-12-22
WO2011134919A3 (en) 2013-01-24
JP2013524824A (ja) 2013-06-20
PT2563906T (pt) 2018-02-16
US20130130316A1 (en) 2013-05-23
KR101828624B1 (ko) 2018-02-12
CA2795461C (en) 2018-04-24
AU2011246502B2 (en) 2014-08-28
KR20130094723A (ko) 2013-08-26
PT3330370T (pt) 2021-05-11
EP3862423A1 (en) 2021-08-11
SG185014A1 (en) 2012-11-29
JP5980772B2 (ja) 2016-08-31
RU2012150283A (ru) 2014-06-10
DK2563906T3 (en) 2018-02-05
PL2563906T3 (pl) 2018-04-30
BR112012027430B1 (pt) 2020-04-07
CN102858954A (zh) 2013-01-02
EP3330370B1 (en) 2021-02-24
CN107254499B (zh) 2021-09-17
MX2012012528A (es) 2012-11-23
EP2563906B1 (en) 2017-11-08
CA2795461A1 (en) 2011-11-03
IL222454A0 (en) 2012-12-31
RU2577972C2 (ru) 2016-03-20
ES2870469T3 (es) 2021-10-27
EP3330370A1 (en) 2018-06-06
ES2659117T3 (es) 2018-03-13
LT3330370T (lt) 2021-06-10

Similar Documents

Publication Publication Date Title
PL2563906T3 (pl) Sposób hodowli komórek cho
TWI563079B (en) Process for fermentation of syngas
EP2729561A4 (en) CELL CULTURE METHOD
IL224321B (en) Methods for detecting diseases or conditions using phagocytic cells
PL2609120T3 (pl) Ulepszony sposób wytwarzania sugammadeksu
EP2545178A4 (en) ACIDIFICATION BY FERMENTATION
PL3825690T3 (pl) Sposób hodowli pojedynczych limfocytów b
GB201110042D0 (en) Growth of cells
SG10201601434RA (en) Cell Culture System
IL227185B (en) A method for growing animal cells
EP2600413A4 (en) Process for production of solar cell
ZA201208686B (en) Microalgae growth pond design
IL223663A (en) Method for collecting algae
EP2650375A4 (en) PROCESS FOR THE PRODUCTION OF CHEMICALS BY CONTINUOUS FERMENTATION
IL228546A0 (en) fermentation process
HUE073112T2 (hu) Eljárás bioüzemanyag elõállítására
SG11201402949RA (en) Process for producing nutrient composition
ZA201304024B (en) Fermentation process involving adjusting specific co-uptake
GB201020333D0 (en) Plant growing unit
PT2454291E (pt) Processo de preparação de poliolefinas
EP2636730A4 (en) METHOD FOR OPEN CULTIVATION OF SILKETS
GB2481212B (en) Apparatus for biogas production
ZA201402773B (en) Use of phenylpyrazolin-3-carboxylates for improving plant yield
ZA201401439B (en) Use of 5-phenyl-or 5-benzyl-2isoxazoline-3carboxylates for improving plant yield
PL2760978T3 (pl) Sposób wytwarzania biogazu